Overview

Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis

Status:
Completed
Trial end date:
2017-06-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if treatment is effective in preventing fractures in women with postmenopausal osteoporosis.
Phase:
Phase 3
Details
Lead Sponsor:
Amgen
Treatments:
Alendronate
Antibodies, Monoclonal